Welcome
Our Treatment Approach
Treatment Details
How do I get started?
- What’s the cost?
- Who can participate?
SET Team
E-learning
- Fragebogen

iasp-2014

See setmarburg.com/research

Questionnaire for the introduction of a new treatment method. CLICK

E-learning E-Health Hessen CLICK

Language

Deutsch
English
Español

Search for:

Reddit Chronic Pain AMA – CLICK

Pain developments

Immersive virtual reality in children with upper limb injuries: findings from a feasibility study - Phelan I, Furness PJ, Dunn HD, Carrion-Plaza A, Matsangidou M, Dimitri P, Lindley S.

PURPOSE: Children who sustain Upper Limb Injuries (ULIs), including fractures and burns, may undergo intensive rehabilitation. The discomfort of therapy can reduce their compliance, limit their range of motion (ROM) and lead to chronic pain. Virtual Realit... (Source: SafetyLit)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free. [...]

Stratus(TM) Medical receives CE Mark for Nimbus(R) RF Multitined Expandable Electrode and Vesta(TM) RF Cannula

MAGNOLIA, Texas, June 23, 2021 -- (Healthcare Sales & Marketing Network) -- Stratus Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced today it received CE Mark (Conformité Européenne)... Devices, Regulatory Stratus Medical, Nimbus, Multitined Expandable Electrode, Vesta, RF Cannula (Source: HSMN NewsFeed) [...]

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients

RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with congenital heart… [...]

Seeking a treatment for IBS pain in tarantula venom

(American Chemical Society) For patients who have inflammatory bowel syndrome (IBS), the condition is literally a pain in the gut. Chronic -- or long-term -- abdominal pain is common, and there are currently no effective treatment options for this debilitating symptom. In a new study in ACS Pharmacology& Translational Science, researchers identify a new potential source of relief: a molecule derived from spider venom. In experiments with mice, they found that one dose could stop symptoms associated with IBS pain. (Source: EurekAlert! - Medicine and Health) [...]

Western high-fat diet can cause chronic pain, according to UT Health San Antonio-led team

(University of Texas Health Science Center at San Antonio) A typical Western high-fat diet can increase the risk of painful disorders common in people with conditions such as diabetes or obesity, according to a groundbreaking paper authored by a team led by The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio. (Source: EurekAlert! - Biology) [...]

Blood Shortage Causes Surgery Delays in New England

Title: Blood Shortage Causes Surgery Delays in New EnglandCategory: Health NewsCreated: 6/21/2021 12:00:00 AMLast Editorial Review: 6/21/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running. [...]

Pivoting to Virtual Delivery for Managing Chronic Pain Pivoting to Virtual Delivery for Managing Chronic Pain

The COVID-19 pandemic has elevated the role of virtual technology in the delivery of nonpharmacological chronic pain treatments, but it has also disrupted research in this field.Pain (Source: Medscape Today Headlines) [...]

Apps 'valuable tool' for patients during pandemic

(Anglia Ruskin University) Smartphone apps have proved invaluable for helping people manage chronic pain during the COVID-19 pandemic, but researchers warn that the need for information sharing and education in this area is being neglected. (Source: EurekAlert! - Social and Behavioral Science) [...]

We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back?

At my animal hospital in upstate New York, an epicenter of the U.S. tick epidemic, my dog Fawn lets out a whimper as the veterinarian injects her with her annual Lyme disease shot. I roll my eyes. She doesn’t know how good she has it. The injection means that if a tick bites her (and in rural New York, a tick always does), the creepy crawly will feast on dog blood that’s been supercharged with a Lyme bacteria-killing substance, and Lyme disease won’t be transmitted to Fawn. I wish I could be shot up with that superpower. Currently, there is… [...]

Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report

A year and a half into the pandemic, the condition known as Long COVID continues to stump doctors. A significant number of patients develop long-term symptoms after catching COVID-19, but it hasn’t been clear why that happens, who is likely to get sick or even how many people continue to suffer. A large new study may help form some answers to those questions. In line with prior estimates, it finds that almost a quarter of people infected with the virus develop at least one lingering health problem, and that most Long COVID symptoms are more commonly reported by women than… [...]

Chronic Headache Pain Linked to Suicide Attempts Chronic Headache Pain Linked to Suicide Attempts

US veterans with chronic headache pain have a higher increased risk of attempting suicide than their counterparts with chronic neck or back pain, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free. [...]

Doctors May Be Overprescribing Opioids After Surgeries

Title: Doctors May Be Overprescribing Opioids After SurgeriesCategory: Health NewsCreated: 6/14/2021 12:00:00 AMLast Editorial Review: 6/14/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General) [...]

Dacrocystitis in a Teenager?

Discussion Tears are produced in the lacrimal gland which resides in the upper outer quadrant of the eye. The tears flow across the eye medially and are collected in the superior and inferior puncta which drain into their respective canaliculi, and these drain into a common canaliculus. Tears then pass through the valve of Rosenmuler into the lacrimal sac where they are collected. Tears then pass through the nasolacrimal duct, through the distal valve of Hasner and into the nasal cavity. Vascular connections are extensive in this anatomic area and veins do not have valves. Therefore infections can spread easily… [...]

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia

Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duration of remission and significantly improved depth of remission.[1] With I+V, undetectable minimal residual disease (uMRD) in… [...]

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible

Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefing and will be presented as a late-breaking abstract during the EHA Virtual Congress (Abstract… [...]

Sleep and injury risk - Huang K, Ihm J.

Sleep has been found to have wide-ranging effects on sports performance and overall well-being. Recent research has found evidence relating chronic suboptimal sleep with the risk of musculoskeletal pain and sports injury. The amount of sleep that consisten... (Source: SafetyLit)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running. [...]

Gene Editing Technique Corrects Sickle Cell Disease in Mice

Title: Gene Editing Technique Corrects Sickle Cell Disease in MiceCategory: Health NewsCreated: 6/10/2021 12:00:00 AMLast Editorial Review: 6/10/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General) [...]

Some Patients Are Reporting Long COVID Recoveries —But Experts Still Don’t Fully Understand Why

A few months ago, Lana Lynch had resigned herself to never getting better. Months after testing positive for COVID-19, she still felt fatigued, still got daily headaches, still had to carefully regulate how much she exerted herself each day. She was coming to terms with her new normal—until she didn’t have to. After receiving her second dose of the Pfizer-BioNTech COVID-19 vaccine in May, Lynch, a 32-year-old from Texas, noticed that she wasn’t quite so tired anymore. She could get through a yoga class without hitting a wall. “I felt like I had some energy,” she says, “but I didn’t… [...]

Chronic pain in adults 2017

This report explores the responses to questions on chronic pain in the 2017 health survey for England. (Source: NHS Networks) [...]

Senior care coordination startup DUOS emerges from stealth, the Arthritis Foundation rolls out chronic pain app and more digital health news briefs

Also: CarePort launches a new system to rate skilled nursing facilities, and Fertility Focus rolls out a wearable that helps track ovulation. (Source: mobihealthnews) [...]

Share this: